Skip to content

Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization

Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02072655
Acronym
CareSSE
Enrollment
40
Registered
2014-02-26
Start date
2014-01-31
Completion date
2016-01-31
Last updated
2016-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoma

Brief summary

In the early 2000s , professional and patient organizations are mobilizing to highlight the psychosocial impact of cancer disease , not only during but also after the acute phase. In 2003, the government launched the Cancer Plan I reinforced in December 2011 by the Cancer Plan II whose objectives include : Develop a personalized care taking into account the pain and psychological and social support and increase opportunities for patients to benefit from supportive care and promote the professional integration . This study aims to show that beyond the immediate benefits of the social aesthetic cares in hospital (direct soothing, improving the quality of the skin injured by chemotherapy , feeling of escape ... ), these treatments can also affect quality of life for patients during and after hospitalization. They also may have an impact on the maintenance of social and / or professional satisfactory throughout the planned chemotherapy aplastic period .

Interventions

* care of the face * skin cleansing with cleansing milk to remove impurities * a gentle scrub to exfoliate and cleanse the skin * a relaxing massage * moisturizing mask * application of a moisturizer suited to specific patient skin: skin reactivity, dehydration ... * care manicure / pedicure, * massages * makeup, advice (scarves, wigs care products adapted to the skin changes ...) and helping relationship.

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 18 to 65 years old * Hospitalized in the Hematology care unit in UH Angers * Initial Hodgkin lymphoma, diffuse large B-cell lymphoma and mantle cell lymphoma * Without previous socio-aesthetic care.

Exclusion criteria

* Age \<18 years old. * Patient protected by the law. * Patient at end of life. * Patient unable to respond to the questionnaire. * Previous Socio aesthetic care.

Design outcomes

Primary

MeasureTime frameDescription
Quality of life scoreChange form baseline in Quality of life score at an average of 5 months (4 to 6 cycles of chemotherapy).* For patients in control group, arbitrarily during their fifth cycle of chemotherapy * For patients in interventional group during the course of chemotherapy after the third socio-aesthetic care, or at the latest, at the sixth treatment.

Secondary

MeasureTime frame
Coopersmith Self-esteem inventoryChange form baseline in Coopersmith Self-esteem inventory score at an average of 5 months (4 to 6 cycles of chemotherapy).
Body Image Scale assessmentChange form baseline in body image scale assessment score at an average of 5 months (4 to 6 cycles of chemotherapy).
Social life assessmentChange form baseline in social life assessment score at an average of 5 months (4 to 6 cycles of chemotherapy).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026